JBSAY Stock DD JBS S.A. 10/12/2014 15:20:23

Recursion and Exscientia Join Forces for Advanced Drug Discovery Two trailblazers in the field of AI-driven drug discovery, Recursion and Exscientia, have officially merged to create a robust entity focused on transforming the landscape of drug development. This amalgamation marks a significant milestone in their shared mission to expedite the discovery of innovative...

Introducing Ergodyne's Type 2 Safety Helmets Ergodyne has unveiled its latest innovation in safety gear, the new Type 2 Safety Helmets, designed to balance familiar aesthetics with enhanced protection. These helmets aim to ease worker reluctance towards new equipment by merging the classic design of a full brim hard hat with the advanced safety features that Type 2...

Palantir Technologies: An Overview of Current Stock Trends Palantir Technologies (NASDAQ: PLTR) has recently experienced fluctuations in its stock prices, especially after being announced as a new member of the NASDAQ 100. In the days following this announcement, investors observed a pullback of more than 5%, which can be closely tied to broader market trends influenced...

Citi dropped a bomb on Woodside Energy Group back when they revised their outlook, cutting the price target from AUD 24.50 to AUD 23.00 while keeping that pesky Sell rating in play. Why? Well, investor nerves around dividends and looming corporate mergers were in the air like a bad hangover at the trading desk. Citi’s Reckoning: EPS Boost or Dividend Squeeze? The update...

Understanding the Class Action Lawsuit Against Lantheus Holdings, Inc. Investors in Lantheus Holdings, Inc. (NASDAQ: LNTH) should be aware of a class action lawsuit that has been initiated, which could represent a significant opportunity for those who believe they've suffered losses due to the company's actions. This notable legal action is spearheaded by the reputable...